|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2500100860 |
|
最近更新日期: Date of Last Refreshed on: |
2025-04-16 15:08:03 |
|
注册时间: Date of Registration: |
2025-04-16 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
肌少症老年人运动干预的前瞻性随机对照研究 |
|
Public title: |
A Prospective Randomized Controlled Study on Exercise Intervention for Sarcopenia in Elderly |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
肌少症老年人运动干预的前瞻性随机对照研究 |
|
Scientific title: |
A Prospective Randomized Controlled Study on Exercise Intervention for Sarcopenia in Elderly |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
梁美华 |
研究负责人: |
唐慧怡,张晓辉 |
|
Applicant: |
Liang Meihua |
Study leader: |
Tang Huiyi, Zhang Xiaohui |
|
申请注册联系人电话: Applicant telephone: |
+86 156 2509 7602 |
研究负责人电话: Study leader's telephone: |
+86 132 6506 9707 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
liangmh987321@163.com |
研究负责人电子邮件: Study leader's E-mail: |
584524673@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
广州省广州市天河区广州大道中1268号 |
研究负责人通讯地址: |
广州省广州市天河区广州大道中1268号 |
|
Applicant address: |
1268 Middle Guangzhou Avenue, Tianhe District, Guangzhou, Guangdong, China |
Study leader's address: |
1268 Middle Guangzhou Avenue, Tianhe District, Guangzhou, Guangdong, China |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
广州体育学院 |
||
|
Applicant's institution: |
Guangzhou Sport University |
||
|
研究负责人所在单位: |
广州体育学院 |
||
|
Affiliation of the Leader: |
Guangzhou Sport University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
2025LCLL-047 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
广州体育学院伦理审查委员会 |
||
|
Name of the ethic committee: |
Human Experimental Ethics Inspection of Guangzhou Sport University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-04-01 00:00:00 |
||
|
伦理委员会联系人: |
李良鸣 |
||
|
Contact Name of the ethic committee: |
Li Liangming |
||
|
伦理委员会联系地址: |
广州省广州市天河区广州大道中1268号 |
||
|
Contact Address of the ethic committee: |
1268 Middle Guangzhou Avenue, Tianhe District, Guangzhou, Guangdong, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 136 0008 9581 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
广州体育学院 |
||||||||||||||||||||||
|
Primary sponsor: |
Guangzhou Sport University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
广州省广州市天河区广州大道中1268号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
1268 Guangzhou Avenue, Guangzhou, Guangdong, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
多中心运动-营养干预促进健康的中国方案 2020YFC2002904 |
||||||||||||||||||||||
|
Source(s) of funding: |
Multicenter Exercise-Nutrition Intervention for Health Promotion: The China Program 2020YFC2002904 |
||||||||||||||||||||||
|
Target disease: |
Sarcopenia |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
本研究拟通过多组分训练(抗阻训练/平衡训练/有氧运动/综合方案)、远程监测指导(如可穿戴设备、移动应用APP反馈)、社交化运动干预等多种形式,评估其对社区肌少症患者肌肉功能、活动能力及生活质量的干预效果,为制定个性化康复方案提供科学依据。 |
||||||||||||||||||||||
|
Objectives of Study: |
This study aims to evaluate the effects of multi-component training (resistance/balance/aerobic exercise/comprehensive programs), telemonitoring guidance (e.g., wearable devices, mobile app feedback), and socialized exercise interventions on muscle function, mobility, and quality of life in community-dwelling older adults with sarcopenia, thereby providing scientific evidence for developing personalized rehabilitation protocols. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.年龄:60岁及以上社区老年人 2.性别:不限 3.健康状况:经专业评估确诊为肌少症患者(符合亚洲肌少症工作组诊断标准) 5.职业:社区常住居民,无特定职业限制 |
||||||||||||||||||||||
|
Inclusion criteria |
1. Age: Community-dwelling adults aged >=60 years 2. Gender: No restriction 3. Health Status: Clinically diagnosed with sarcopenia (meeting Asian Working Group for Sarcopenia diagnostic criteria) 4. Occupation: Permanent community residents with no specific occupational restrictions |
||||||||||||||||||||||
|
排除标准: |
1. 严重心血管或脑血管疾病 2. 可能影响身体功能评估或训练的骨骼 / 关节疾病 3. 可能影响干预的其他医疗状况 4. 认知障碍(简易精神状态检查评分<24 或临床诊断) 5. 目前正在参与其他干预项目 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. Severe cardiovascular or cerebrovascular diseases 2. Skeletal/joint disorders that may affect physical function assessment or training 3. Other medical conditions that may interfere with the intervention 4. Cognitive impairment (MMSE score <24 or clinical diagnosis) 5. Currently participating in other intervention programs |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2025-05-01 00:00:00至 To 2027-06-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2025-05-01 00:00:00 至 To 2026-12-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
按区组、性别、年龄分层,随机抽样分组,分为干预组和对照组,分配比例为1:1。随机化序列由研究团队中独立于干预实施和评估的人员负责生成,通过密封信封分配至两组。 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Participants were stratified by region, sex, and age, then randomly allocated to intervention and control groups with a 1:1 allocation ratio. The randomization sequence was generated by independent personnel not involved in intervention delivery or outcome assessment, with group assignments implemented through sealed opaque envelopes. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
结局评估者和数据分析人员在整个试验过程中对分组情况保持盲态。 |
|
Blinding: |
Outcome assessors and data analysts remain blinded to group allocation throughout the trial. |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
不共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Do not share |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
使用病例记录表进行数据收集和管理 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
Data collection and management will be conducted using standardized case report forms (CRFs) |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |